Line et al. [33] reported that low glutamine amounts were associated with older age, advanced-stage cancer, low albumin levels, high carcinoembryonic antigen levels, increased C-reactive protein levels, higher modified Glasgow prognostic scores, and augmented proinflammatory cytokine levels in colorectal cancer-affected patients. This evidence concerns the gene CEACAM5 and cancer.